Matriptase/MT-SP1 is a novel tumor-associated type II transmembrane serine protease that is highly expressed in the epidermis, thymic stroma, and other epithelia. A null mutation was introduced into the Matriptase/MT-SP1 gene of mice to determine the role of Matriptase/ MT-SP1 in epidermal development and neoplasia. Matriptase/MT-SP1-de®cient mice developed to term but uniformly died within 48 h of birth. All epidermal surfaces of newborn mice were grossly abnormal with a dry, red, shiny, and wrinkled appearance. Matriptase/ MT-SP1-de®ciency caused striking malformations of the stratum corneum, characterized by dysmorphic and pleomorphic corneocytes and the absence of vesicular bodies in transitional layer cells. This aberrant skin development seriously compromised both inward and outward epidermal barrier function, leading to the rapid and fatal dehydration of Matriptase/MT-SP1-de®cient pups. Loss of Matriptase/MT-SP1 also seriously aected hair follicle development resulting in generalized follicular hypoplasia, absence of erupted vibrissae, lack of vibrissal hair canal formation, ingrown vibrissae, and wholesale abortion of vibrissal follicles. Furthermore, Matriptase/MT-SP1-de®ciency resulted in dramatically increased thymocyte apoptosis, and depletion of thymocytes. This study demonstrates that Matriptase/MT-SP1 has pleiotropic functions in the development of the epidermis, hair follicles, and cellular immune system.
Introduction
Proteolytic modi®cation of the extracellular environment is essential for all aspects of life of a multicellular organism. Extracellular proteolysis regulates key processes such as cell growth, dierentiation, adhesion, migration, and programmed cell death (Werb, 1997) . Dysregulated extracellular proteolysis is also intimately associated with the genesis and progression of a number of chronic diseases including cancer, cardiovascular disease, and neuronal degeneration (Andreasen et al., 2000; Esler and Wolfe, 2001; Luttun et al., 2000; Matrisian, 1999; Werb et al., 1999) . Several families of secreted or cell surface-associated proteases have been studied extensively in the context of physiological and pathological tissue remodeling. These include the plasminogen activation system, the matrix metalloproteinases, the ADAM proteases, the ADAMTS proteases, and the cathepsins (Andreasen et al., 1986; Blobel, 2000; Tang, 2001; Turk et al., 2000; Vu and Werb, 2000) .
The type II transmembrane serine proteases (TTSPs) is a recently recognized and rapidly expanding family of mammalian cell surface-associated serine proteases with a unique modular structure (Hooper et al., 2001) . The family currently includes enterokinase, corin, human airway trypsin-like protease, hepsin, TMPRSS2, TMPRSS3, and Matriptase/MT-SP1 (see below). TTSPs have also been reported in non-mammalian vertebrates and in invertebrates (Appel et al., 1993; Yamada et al., 2000) . The common structural features of the TTSPs include a short N-terminal cytoplasmic tail, a signal anchor that functions as a transmembrane domain, and a C-terminal serine protease domain. The transmembrane and serine protease domains are separated by a linker region consisting of a variable series of modular protein interaction domains that include complement factor 1R ± urchin embryonic growth factor ± bone morphogenetic protein (CUB) domains, low-density lipoprotein receptor (LDLR) repeats, group a scavenger receptor domains, Frizzled domains, and meprin-A-5 protein-mu (MAM) domains (Hooper et al., 2001) . TTSPs are likely synthesized as pro-enzymes that require proteolytic cleavage for function. Preliminary studies suggest that some TTSPs are shed from the cell surface, either prior to activation or, possibly, directly associated with the activation process (Takeuchi et al., 2000) . The biological functions of most TTSPs still need to be elucidated. Enterokinase, the prototypic member of this class of proteases, is the physiological activator of trypsinogen in the digestive tract, and in this capacity is the initiator of a proteolytic cascade reaction that leads to the activation of pro-carboxypeptidase, chymotrypsinogen, and proelastase (Mann and Mann, 1994) . Mutations in the TMPRSS3 gene were recently shown to be associated with congenital and childhood autosomal recessive deafness (Scott et al., 2001 ). Corin appears to be involved in pro-hormone processing, acting as a proatrial natriuretic peptide-converting enzyme . Taken together, these ®ndings suggest that TTSPs may have many biologically diverse functions in development and homeostasis.
The type II transmembrane serine protease Matriptase/MT-SP1 (also known as ST14 and TAGD-15) was ®rst described as a transcript that was frequently absent in human colon cancer (Zhang et al., 1998) . Subsequently, Matriptase/MT-SP1 was independently isolated as a serine protease expressed in a prostate carcinoma cell line, as a serine protease secreted in human breast milk, and as a serine protease present in ovarian cancer but not in normal ovarian tissue (Lin et al., 1999; Takeuchi et al., 1999; Tanimoto et al., 2001) . Epithin, the murine orthologue of Matriptase/MT-SP1, was isolated from fetal thymic stromal cells (Kim et al., 1999) . Matriptase/MT-SP1 contains a transmembrane signal anchor, separated from the chymotrypsin-like serine protease domain by two CUB domains and four LDLR repeats (Kim et al., 1999; Takeuchi et al., 1999; Tanimoto et al., 2001) . Matriptase/MT-SP1 has a widespread expression in normal epithelial tissues, including the skin, thymic stroma, gastrointestinal tract, kidney, lung, prostate, and mammary gland (Kim et al., 1999; Oberst et al., 2001; Takeuchi et al., 1999) . Matriptase/MT-SP1 has been proposed to play an important role in carcinoma progression. The novel protease is expressed in a wide variety of human tumors of epithelial origin, is a prognostic factor in ovarian carcinoma, and is a potential activator of key molecules associated with tumor invasion and metastasis (see below) (Oberst et al., 2001) . Matriptase/MT-SP1 is synthesized as a catalytically inactive single-chain zymogen. The physiological activator of Matriptase/ MT-SP1 remains to be identi®ed, but Matriptase/MT-SP1 can be activated in vitro by a factor that is present in human serum (Benaud et al., 2001) . Soluble Matriptase/MT-SP1 is present in the conditioned medium of cultured cells and in milk, suggesting that proteolytic shedding of Matriptase/MT-SP1 from the cell surface takes place. Soluble Matriptase/MT-SP1 has been found in both a free form and in association with the Kunitz-type serine protease inhibitor, hepatocyte growth factor activator inhibitor-1 (Lin et al., 1999) . Matriptase/MT-SP1 is an ecient activator of pro-urokinase plasminogen activator (pro-uPA), hepatocyte growth factor/scatter factor (HGF/SF), and protease activated receptor-2 (PAR-2) in vitro, and the protease could have pleiotropic functions in the activation of proteolytic cascades, growth factor activation, and activation of G-protein coupled receptors (Lee et al., 2000; Takeuchi et al., 2000) .
To identify novel serine proteases involved in epidermal remodeling, a systematic screening for serine protease genes speci®cally upregulated in keratinocytes during skin wound healing and squamous carcinoma was initiated. In the study, Matriptase/MT-SP1 was revealed to be one of several serine proteases expressed in basal keratinocytes in the skin, and the expression of Matriptase/MT-SP1 was strongly upregulated in migrating and proliferating keratinocytes in®ltrating the provisional wound matrix. We also determined that Matriptase/MT-SP1 was frequently expressed in cancer originating from strati®ed epithelium (data not shown).
Mice de®cient in Matriptase/MT-SP1 were generated in order to determine the function of Matriptase/MT-SP1 in epidermal development and neoplasia. We report that Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymocyte survival.
Results

Generation of Matriptase/MT-SP1-deficient mice
The strategy used to generate a null mutation in the murine Matriptase/MT-SP1 gene in embryonic stem (ES) cell is depicted in Figure 1a . No phage clones were isolated that contained the ®rst 143 bp of the published cDNA sequence (Kim et al., 1999) . The ®rst exon identi®ed, starting at nucleotide (nt.) 144 in the cDNA sequence, is therefore in the following designated putative exon 2' and the upstream intron sequence is designated`putative intron 1'. In the Matriptase/MT-SP1 targeting vector, a 350 bp fragment containing the 3' portion of the putative intron 1 and most of the putative exon 2 encoding the signal anchor, was replaced by an HPRT cassette located in the opposite transcriptional orientation relative to the transcription of the Matriptase/MT-SP1 gene. Homologous recombination of this targeting vector into the Matriptase/MT-SP1 locus removes DNA sequences encoding the Nterminal 19 of the 24 amino acids (aa) of the signal anchor required for membrane translocation of Matriptase/MT-SP1. This deletion also introduces a frameshift mutation in the targeted Matriptase/MT-SP1 locus through the splicing of the putative exon 1 to the putative exon 3, leading to a truncated protein containing just the N-terminal 27 aa of Matriptase/MT-SP1. Mice homozygous for this targeted deletion in the Matriptase/MT-SP1 gene (Matriptase/MT-SP1 7/7 mice) were generated by blastocyst injection of a targeted ES cell clone followed by interbreeding of the ospring of chimeric mice transmitting the targeted allele through the germ line ( Figure 1b) . As would be predicted from the targeting strategy, Northern blot hybridization of RNA from whole newborn Matriptase/ MT-SP1 7/7 pups demonstrated the presence of a single transcript of similar or slightly increased mobility compared to RNA from Matriptase/MT-SP1 +/+ littermates. This suggests that a single putative exon 1 ± putative exon 3 splicing event was taking place in transcripts from the targeted Matriptase/MT-SP1 allele (Figure 2a) . To further verify the introduction of a null mutation, we performed RT ± PCR analysis of total RNA from whole newborn Matriptase/MT-SP1 7/7 and Matriptase/MT-SP1 +/+ pups using primer pairs hybridizing to putative exons 1 and 4 (Figure 2b ,c). RT ± PCR ampli®cation with this primer pair resulted in a PCR product of approximately 280 bp using RNA from Matriptase/MT-SP1 7/7 pups, again indicative of a putative exon 1 ± putative exon 3 splicing event. Identical results were obtained with an independent, non-overlapping putative exon 1 ± putative exon 4 primer pair (data not shown). The 280 bp RT ± PCR fragment generated with RNA from Matriptase/MT-SP1 7/7 pups was cloned and sequenced ( Figure 2c ). This sequence analysis veri®ed the presence of a putative exon 1 ± putative exon 3 splice event and the subsequent introduction of a frameshift mutation in the targeted Matriptase/MT-SP1 allele leading to a truncated protein terminating at a TGA codon located at nt. 344 of the Matriptase/MT-SP1 sequence (Kim et al., 1999) . In conclusion, the signal anchor is deleted from the targeted Matriptase/MT-SP1 allele, a frameshift introduced at position 305, and the modi®ed allele has the capacity to express a cytoplasmic 40 aa peptide containing the Nterminal 27 of the 855 aa of the mature Matriptase/MT-SP1 protein (Figure 2c ). The fate of this N-terminal 27 aa cytoplasmic peptide was not studied.
Postnatal lethality in Matriptase/MT-SP1-deficient mice
Matriptase/MT-SP1 was dispensable for the development to term. Genotype analysis of newborn ospring of Matriptase/MT-SP1 +/7 breeding pairs revealed that the targeted Matriptase/MT-SP1 allele was present in the expected Mendelian frequency (Figure 3a) . Of 119 pups from 12 litters from Matriptase/MT-SP1 +/7 parents that could be followed from the time of birth, 25 were Matriptase/MT-SP1 +/+ , 62 Matriptase/MT-SP1 +/7 , and 32 Matriptase/MT-SP1 7/7 . However, no Matriptase/MT-SP1 7/7 ospring were detected at weaning, indicating that Matriptase/MT-SP1 is required for postnatal survival (Figure 3b ). Of 57 weaning-age ospring from eight litters, 41 were Matriptase/MT-SP1 +/7 and 16 Matriptase/MT-SP1 +/+ . The mortality of newborn Matriptase/MT-SP1 pups was investigated in detail in eight litters from Matriptase/MT-SP1 +/7 parents that were monitored closely from the time of birth. Of the 20 pups in this study cohort that died within 48 h, 16 were Matriptase/MT-SP1 7/7 , 4 were Matriptase/MT-SP1 +/7 , and no pups were Matriptase/ MT-SP1 +/+ (P50.001, Chi-square analysis, two-tailed). No Matriptase/MT-SP1 7/7 pups in this cohort were alive more than 48 h after birth. Taken together, these data demonstrate that Matriptase/MT-SP1 is required for survival beyond the ®rst two days after birth.
Abnormal epidermal development in Matriptase/MT-SP1-deficient mice Newborn Matriptase/MT-SP1 7/7 pups displayed an abnormally dry, wrinkled, red, and shiny skin. All body surfaces were aected including the trunk, limbs, tail, (Figure 4b and c). In addition to progressive dehydration beginning immediately after birth (see below), this dierence in size could in part also be attributed to selective maternal neglect of Matriptase/MT-SP1 7/7 pups or to the inability of some Matriptase/MT-SP1 7/7 pups to nurse properly. Thus, milk spots in the stomachs were observed in just 6 out of 14 Matriptase/MT-SP1 7/7 pups (43%) versus 27 out of 29 Matriptase/MT-SP1 + pups (93%) that could be followed closely for at least a 24 h period.
A comprehensive histological analysis was performed on Matriptase/MT-SP1 7/7 pups and their associated 7/7 pups (lane 2). The RT ± PCR analysis was performed with primers complementary to sequences in the putative exon 1 (p07 (c, lower panel), nt. 59 ± 80 in the Matriptase/MT-SP1 cDNA sequence (Kim et al., 1999) ) and putative exon 4 (p06 (c, lower panel), nt. 477 ± 498). The presence of a PCR product with an approximate size of 280 bp in lane 2 demonstrates the putative exon 1 ± putative exon 3 splicing event within the targeted allele. Lane 3; 100 bp DNA ladder. (c) RT ± PCR products generated in b were subcloned into plasmid vectors and sequenced. Upper panel, sequence of the putative exon 1 ± exon 3 border. The putative exon 2 (boxed area in bottom panel) is deleted in transcripts from the targeted Matriptase/MT-SP1 allele to generate a frameshift mutation and translational termination at a TGA codon located at nt. 344 (shaded box)
Type II transmembrane serine protease in development K List et al pups demonstrated a distinct subnuclear vacuolization in the resorptive epithelium or edema of the underlying stroma in the small intestine and colon. This abnormality was probably secondary to starvation and dehydration, as Matriptase/MT-SP1 7/7 pups with abundant milk in the stomach presented an unremarkable resorptive epithelium (data not shown). The epidermis, however, of Matriptase/MT-SP1 7/7 pups demonstrated striking abnormalities as expected from the macroscopic appearance of the skin ( Figure 5 ). In normal newborn mice, the¯attened corneocytes of the stratum corneum form a characteristic`basket weave' pattern generated by a meshwork of interlocking layers of corneocytes connected by desmosomes (Nemes and Steinert, 1999) . The intercorneocyte lacunae of the basket weave meshwork are abundant in intercorneal lipids that are extracted during routine tissue processing, giving rise to the appearance of empty intercorneocyte lacunae (Figure 5a ). After glutaraldehyde ®xation, the intercorneal lipids are preserved and the stratum corneum appears as the outermost highly opaque layer of the epidermis with strati®ed layers of attened corneocytes after toluidine blue staining (Figure 5c ). The basal, spinous, and granular layers of the epidermis of Matriptase/MT-SP1 7/7 pups were not conspicuously morphologically dierent from Matriptase/MT-SP1 + littermates when examined by light microscopy (Figure 5b,d) . However, the stratum corneum presented striking abnormalities in all Matriptase/MT-SP1 7/7 pups. Very few intercorneocyte lacunae could be observed, giving rise to a very compact appearance of the stratum corneum after hematoxylin and eosin (h and e) staining (compare Figure 5a,b) . At higher magni®cation, following glutaraldehyde ®xation and toluidine blue staining of thin sections, the corneocytes appeared clearly dysmorphic and pleomorphic, with a swollen, rather than attened, appearance of individual corneocytes. Moreover, the stratum corneum of all epidermal surfaces displayed a less organized strati®cation (compare Figure 5c ,d). Taken together, these data clearly demonstrate an essential function of Matriptase/MT-SP1 in stratum corneum development.
The stratum corneum is formed from an inner layer of living keratinocytes that migrate upwards while undergoing a highly complex genetic program of terminal dierentiation. Four distinct key events (1) formation of desmosomal adherence junctions between keratinocytes, (2) intracellular accumulation of specialized keratins, (3) formation of a peripheral corni®ed envelope, and (4) extrusion of specialized intercorneocyte lipids (Nemes and Steinert, 1999; Roop, 1995) ; see Discussion for further details). Desmosomes, appearing as`spines' decorating the surface of basal and spinous layer cells in light microscopy ( Figure 5d ) and as¯attened electron-dense disks in transmission electron microscopy (Figure 6b ), were clearly visible in the Matriptase/MT-SP1 7/7 epidermis. Also, the abnormal stratum corneum formation in Matriptase/ MT-SP1 7/7 pups was not directly associated with major changes in the expression of several keratinocyte-speci®c dierentiation markers. The onset and level of expression of basal-layer markers (keratin 5 and 14), suprabasal layer markers (keratin 1 and 10), and granular/corneum-layer markers (®llagrin and loricrin) were not appreciably altered (data not shown). Keratohyalin granules formed normally in the granular and transitional layer of the Matriptase/ MT-SP1 7/7 epidermis ( Figure 6b ). Apoptosis was very infrequent in the basal layer of the epidermis of both Matriptase/MT-SP1 7/7 and littermate control pups, and no signi®cant dierence was observed in cell proliferation as assessed by proliferating cell nuclear antigen-staining (data not shown).
Although the corneocytes of the Matriptase/MT-SP1 7/7 epidermis were strikingly dysmorphic when visualized by light microscopy, the corni®ed envelope itself presented no obvious morphological changes when examined by transmission electron microscopy ( Figure 6 ). However, striking dierences in transitional cell vesicular body content were immediately evident. In control mice, numerous intracytoplasmic vesicular bodies were visible in Matriptase/MT-SP1 + transitional cells. These vesicular bodies, which gives rise to the majority of the intercorneocyte lipids of the normal epidermis, were located just below the plasma membrane and also accumulated in the extracellular space between transitional layer cells and corneocytes (Figure 6a) . In Matriptase/MT-SP1 7/7 pups, these vesicular structures were entirely absent in transitional cells of the epidermis and in the extracellular space (Figure 6b ). The absence of vesicular bodies was not limited to the epidermis, but was also observed in transitional cells within the hair follicles of Matriptase/ MT-SP1 7/7 mice, suggesting a generalized defect in transitional cell function (data not shown).
Loss of epidermal barrier function in Matriptase/ MT-SP1-deficient skin causes neonatal death
The epidermal water barrier that prevents catastrophic uid loss from the surface of terrestrial vertebrates (Nemes and Steinert, 1999) . Due to the conspicuous stratum corneum defects, the functional integrity of the epidermis of Matriptase/MT-SP1 7/7 pups was investigated using a standard dye permeability assay (Koch et al., 2000) . The ability to exclude histological dyes from penetrating through the epidermis requires an intact epidermal barrier and dye penetration is indicative of abrogated barrier function. Newborn litters from Matriptase/MT-SP1 +/7 intercrosses were stained by submersion in toluidine blue. As expected, Matriptase/MT-SP1 + pups showed minimal epidermal dye penetration, showing that the neonatal epidermis is highly impermeable and functional (Figure 7a ). In contrast, Matriptase/MT-SP1
littermates showed extensive dye penetration across the entire epidermal surface demonstrating a generalized loss of`outwards in' epidermal barrier function. To ascertain whether the abnormal epidermal maturation in Matriptase/MT-SP1 7/7 pups also impaired`inwards out' epidermal barrier function, the rate of¯uid loss through evaporation was determined in Matriptase/ MT-SP1 7/7 and Matriptase/MT-SP1 + pups. Newborn litters of Matriptase/MT-SP1 +/7 parents were separated from their mothers to prevent¯uid intake, and the loss of¯uids at 378C was recorded over a ®ve-hour period in individual pups by monitoring the loss of body weight. The pups were genotyped at the termination of the experiment (Figure 7b) Hair follicle hypoplasia and dysgenesis in Matriptase/ MT-SP1-deficient mice
Vibrissal hairs, which are normally fully developed at birth (Kaufmann and Bart, 1999) , were absent in all Matriptase/MT-SP1 7/7 pups, immediately revealing a role of Matriptase/MT-SP1 in hair follicle development. Examination of the facial area of Matriptase/ MT-SP1 7/7 pups by scanning electron microscopy showed a general absence of both erupted vibrissal hair shafts and vibrissal hair canals (Figure 8a,b) . Interestingly, the snouts of Matriptase/MT-SP1 7/7 pups instead displayed a large number of ellipsoid epidermal +/7 parents were separated from their mother to prevent¯uid intake, and the rate of epithelial¯uid loss was estimated by measuring the reduction of body weight as a function of time. The data are expressed as the average body weight as a percent of initial body weight in Matriptase/MT-SP1 + (squares; n=3) and Matriptase/MT-SP1 7/7 (diamonds; n=3) pups. Error bars indicate standard deviations. One Matriptase/MT-SP1 7/7 pup urinated after 210 min and was excluded from further measurements. *P50.028 to 0.022. **P50.014 to 0.005 (Student's t-test, two-tailed)
Type II transmembrane serine protease in development K List et al protrusions that were uniformly absent in Matriptase/ MT-SP1 + littermate controls (Figure 8c,d ). Although erupted vibrissae were not present, a histological analysis revealed that vibrissal follicles were nevertheless abundant in Matriptase/MT-SP1 7/7 pups ( Figure 8h ). The vibrissal follicles were distinctly hypomorphic (compare Figure 8e ,f, and Figure 8g ,h), but did contain vascular sinuses, inner and outer root sheaths, follicular papillae, hair bulbs, and hair shafts (Figure 8f,h ). In accordance with surface scanning data, no vibrissal hair canals were detected in a comprehensive analysis of serial frontal sections of the facial area of Matriptase/MT-SP1 7/7 pups and the hair shaft of all isolated follicles was uniformly curved and ingrown (Figure 8f,h ). Likely as a directly consequence of this, the nasal area displayed an unusually high number of aborted vibrissal follicle remnants presenting as large follicles in various stages of degeneration embedded in reactive hyperplastic epidermis. The speci®c requirement of Matriptase/ MT-SP1 for the formation of pelage hair could not be determined directly, as all Matriptase/MT-SP1 7/7 pups died before the eruption of body hairs in the littermates. However, a comprehensive histological analysis of skin demonstrated that pelage hair follicles of Matriptase/MT-SP1 7/7 pups displayed marked hypoplasia when compared to hair follicles of Matriptase/MT-SP1 + littermates (Figure 9 ). Speci®-cally, Matriptase/MT-SP1 7/7 skin contained fewer pelage hair follicles that generally penetrated less deeply into the underlying dermis and overlying epidermis, and were more poorly dierentiated ( Figure  9a,b) . Taken together, the data show that Matriptase/ MT-SP1-de®ciency is associated with follicular hypoplasia and dysgenesis.
Accelerated thymocyte apoptosis in Matriptase/MT-SP1-deficient mice
Matriptase/MT-SP1 is abundant in the developing thymic epithelium (Kim et al., 1999) . Moreover, mutations aecting the epidermis often also aect thymic function due to the close ontogenic relationship between the two organs and the expression of a number of epidermal structural genes in the thymic epithelium (Davisson et al., 1994; Flanagan, 1966; Manley, 2000; Nakagawa et al., 1998; Reske-Kunz et al., 1979; Shultz, 1988) . Indeed, the thymus is rich in keratinized epithelium in the form of terminally dierentiated swirls of corni®ed epithelial cells, termed Hassall's bodies (Manley, 2000) . Interestingly, the thymus of all examined Matriptase/MT-SP1 7/7 pups was grossly abnormal as compared to Matriptase/MT-SP1 + littermates (Figure 10 ). Thymocyte apoptosis was widespread throughout both the cortex and the medulla of the thymus of Matriptase/MT-SP1 7/7 pups when analysed histologically by in situ labeling of fragmented DNA by Tunel staining (Figure 10b ). In contrast, the thymus of Matriptase/MT-SP1 + pups demonstrated few apoptotic cells (Figure 10a ). Quantitative¯ow cytometry analysis of immature CD4+CD8+ double positive thymocytes, which represent about 90% of T-lymphocytes in the thymus, revealed a ®vefold increase in the apoptotic index (P50.016), and a corresponding almost 50% reduction in the total number of double positive cells residing in the thymus (P50.003) (Figure 10c,d) . The accelerated thymocyte apoptosis in Matriptase/MT-SP1 7/7 pups appeared to be intrinsic to the thymic environment and not a primary defect in lymphocytes. Thus, other lymphoid tissues examined in Matriptase/MT-SP1 7/7 pups, including the spleen and gut-associated lymphoid tissue, were similar to Matriptase/MT-SP1 + pups presenting no appreciative lymphocyte apoptosis. In conclusion, Matriptase/MT-SP1 is critical for the survival of developing lymphocytes within the thymic microenvironment.
Discussion
This paper shows that the type II transmembrane serine protease Matriptase/MT-SP1 is required for postnatal survival and has an essential function in epidermal, hair follicle and thymic development. The epidermis is a self-renewing, strati®ed epithelium that serves as a ®rst line of defense against the external environment by providing a protective barrier against mechanical, chemical, and biological insults. The epidermis also provides a water-impermeable barrier that prevents excessive loss of body¯uids, a function that is critical for the survival of all terrestrial vertebrates immediately after birth. The epidermal barrier function resides in the stratum corneum, which chie¯y consists of an interlocking meshwork of attened corneocytes connected by desmosomes and intercorneocyte lipids. Water impermeability is conferred to the stratum corneum by an insoluble corni®ed envelope located just beneath the plasma membrane of the corneocytes, and by the surrounding intercorneocyte lipids (Nemes and Steinert, 1999; Roop, 1995) . The stratum corneum is maintained by the constant reproduction of the inner layer of living keratinocytes that migrate upwards while undergoing a complex genetic program of terminal dierentiation. This program includes the formation of desmosomal adherence junctions, the accumulation of specialized keratins that provide mechanical strength to the skin, the accumulation of a complex array of structural proteins, lipids, and enzymes that constitute the corni®ed envelope, and the synthesis, extrusion, and processing of intercorneocyte lipids (Nemes and Steinert, 1999; Roop, 1995) . The data presented here show that Matriptase/MT-SP1 is required for the formation of a functional stratum corneum and the establishment of epidermal barrier function. This de®ciency does not appear to be the consequence of a general developmental delay, as other organ systems such as the musculoskeletal system, the central nervous system, the gastrointestinal tract, the respiratory tract, and the urogenital tract did not demonstrate any signs of immaturity in newborn Matriptase/MT-SP1
7/7
Oncogene Type II transmembrane serine protease in development K List et al pups. Pathological abnormalities in the stratum corneum, with the subsequent breakdown of epidermal barrier function, is seen in an extraordinary variety of skin conditions of diverse etiology that are collectively referred to as ichthyosis. At the genetic level, the loss of barrier function can be caused by an array of defects in the complex machinery required for the proper assembly of keratin ®laments in the corneocyte, the assembly of corni®ed envelope components, the formation of corneocyte adherens junctions, or the assembly of intercorneocyte lipids, as observed in numerous inherited skin diseases or in transgenic mice with dominant or recessive mutations in epidermal components (Nemes and Steinert, 1999; Presland and Dale, 2000; Roop, 1995) . Null, frameshift, or point mutations in genes encoding structural proteins of the corneocyte (e.g., keratins, loricrin), in components of the enzymatic machinery that process and cross-link these structural proteins (e.g., transglutaminase 1), in desmosomal cadherins linking corneocytes together (e.g., desmoglein), or in the enzymes that manufacture and process corni®ed envelope and intercorneocyte lipids (e.g., fatty aldehyde dehydrogenase, arylsulfatase C/cholesterol sulfatase) have all been reported to disrupt epidermal barrier function (De Laurenzi et al., 1996; Elias et al., 2001; Huber et al., 1995; Koch et al., 2000; Kubilus et al., 1979; Matsuki et al., 1998; Russell et al., 1995; Shapiro et al., 1978) . The data presented in this paper strongly suggest that the abrogation of barrier function is related to abnormal extrusion of vesicular bodies in the transitional layer of the cornifying epidermis, which likely aects the formation of the specialized set of crosslinked intercorneocyte lipids that confer epidermal barrier function in conjunction with the corni®ed envelope. Although the short lifespan of Matriptase/MT-SP1
mice did not permit a comprehensive initial description of the role of this protease in hair biology of adult mice, it is clear from the data presented in this paper that Matriptase/MT-SP1 plays a critical role in hair follicle development. Matriptase/MT-SP1 7/7 mice presented with marked, generalized follicular hypoplasia and agenesis of the vibrissal hair canal. Despite their hypoplastic appearance, many follicular structures could, nevertheless, be identi®ed in the vibrissal follicles of Matriptase/MT-SP1 7/7 mice, including the inner and outer root sheaths, follicular papillae, hair bulb, and hair shaft. An exception was the hair canal, which was generally absent. As a consequence of this, the growing vibrissal hair shaft was unable to erupt, instead growing backwards into the vibrissal follicle, likely causing wholesale follicle abortion. Hair canal formation is a poorly understood process, but is believed to occur prior to the emerging hair shaft pushing through the follicle and may include apoptosis of follicular epithelial cells (Davisson and Hardy, 1952; Magerl et al., 2001) . Although a speculative assertion, it is tempting to propose that a common molecular defect underlies the epidermal and hair follicle abnormalities in Matriptase/MT-SP1 7/7 mice. The thymus ful®lls a critical function in Tlymphocyte development through the selection of mature T-lymphocytes from a repertoire of immature T-cell precursors. Only a small proportion of T-cell precursors survives thymic selection and is exported to secondary lymphoid tissues (Sebzda et al., 1999) . The thymic microenvironment provides negative selection against thymocytes that express a T-cell receptor that binds with high anity to self-peptide-MHC complexes (negative thymocyte selection) or are incapable of interacting with self-peptide-MHC complexes (thymocyte death by neglect). Both groups of thymocytes are eliminated through apoptosis, but the exact nature of the stimuli that trigger apoptosis in the thymocytes is not fully understood (Williams and Brady, 2001) . The data presented in this paper show that Matriptase/MT-SP1 has a pivotal role in thymocyte survival by suppressing apoptosis. The thymus of Matriptase/ MT-SP1 7/7 pups was profoundly depleted of immature CD4+CD8+ double positive thymocytes. This ®nding opens several questions to be addressed in future studies as to the function of Matriptase/MT-SP1 in T-cell immunity. Does Matriptase/MT-SP1 promote thymocyte survival by activating or liberating cytokines that favor thymocyte survival, or by The future identi®cation of the speci®c molecular defects underlying the pleiotropic eects of loss of Matriptase/MT-SP1 may represent a challenging undertaking. These defects could include the lack of appropriate growth factor processing, growth factor inactivation, shedding of growth factor receptors, or the direct modi®cation of the extracellular matrix to create the appropriate extracellular environment for keratinocyte dierentiation and thymocyte survival. The essential activities of Matriptase/MT-SP1 are likely to take place directly on the surface of keratinocytes and thymic epithelium due to the high levels of expression of the protease on these cells in particular, and the strict expression of Matriptase/MT-SP1 on epithelial, and not mesenchymal cells, in general. Several possible substrates for Matriptase/MT-SP1 have been proposed from biochemical studies, including the cleavage and activation of pro-uPA, HGF/SF, and PAR-2 (Lee et al., 2000; Takeuchi et al., 2000) . The speci®c relationship between the lack of activation of these factors by Matriptase/MT-SP1 and the eects of Matriptase/MT-SP1 de®ciency described here is not obvious. uPA-de®cient mice have been reported to display reduced epidermal proliferation in the neonatal period (Jensen and Lavker, 1999) . However, uPAde®cient mice display no obvious histological abnormalities in the skin and have normal epidermal function in the absence of other challenging factors (Carmeliet et al., 1994) . Complete de®ciency in PAR-2 has also not been reported to be associated with skin abnormalities (Damiano et al., 1999; Lindner et al., 2000b) . Thus, inappropriate processing of pro-uPA and PAR-2 can essentially be ruled out as a contributing factor to the epidermal and thymic phenotype of Matriptase/MT-SP1 7/7 mice described here. HGF/SF is a pleiotropic regulator of cell growth and dierentiation with possible functions in keratinocyte biology. Keratinocytes express c-met, the receptor for HGF/SF, and display increased mobility in response to HGF/SF in culture (McCawley et al., 1998) . Transgenic overexpression of HGF/SF, intradermal injection of HGF/ SF, or administration of HGF/SF to organ cultures all stimulate hair follicle formation, accelerate hair follicle dierentiation, promote hair growth, and prolong the anagen phase of the hair cycle (Jindo et al., 1998; Lindner et al., 2000a) . HGF/SF 7/7 mice die early in embryonic development due to inappropriate epithelial-mesenchymal interactions (Stella and Comoglio, 1999) and the function of HGF/SF in epidermal 7/7 pups (white bar, n=5) and Matriptase/MT-SP1 + littermates (black bar, n=5) enumerated by¯ow cytometry. *P50.0079, Wilcoxon rank sum test, two-tailed development cannot be determined directly. HGF/SF is secreted by follicular papilla cells and acts as a paracrine factor on neighboring follicular epithelial cells to promote follicle growth. However, both follicular papilla cells and outer root sheath cells express HGF activator, a highly ecient activator of single chain HGF/SF (Lee et al., 2001; Yamazaki et al., 1999) . Moreover, no studies have indicated an eect of HGF/SF on epidermal dierentiation and stratum corneum formation. It is, thus, altogether conceivable that Matriptase/MT-SP1 functions in epidermal development by a novel mechanism that is independent of uPA, PAR-2, or HGF/SF activation.
In conclusion, this study demonstrates that Matriptase/MT-SP1 is required for postnatal survival and has pleiotropic functions in epidermal dierentiation, hair follicle development, and thymic homeostasis.
Materials and methods
Construction of targeting vector and generation of transgenic mice
A mouse genomic DNA fragment was isolated from a 129/ SvJ bacteriophage library using a 169 bp 32 P-labelled synthetic oligonucleotide probe corresponding to nt. 83 to 252 of the published Matriptase/MT-SP1 cDNA sequence (Kim et al., 1999) . The targeting vector was generated from a 7.5 kb EcoRI-NotI fragment containing the putative intron 1 through the putative exon 4, that was subcloned and characterized extensively by restriction mapping, Southern blotting, and sequencing of the intron/exon boundaries. The targeting vector was constructed by placing a PGK-HPRT cassette into the AscI site of the pKO ScramblerV924 gene targeting vector (Stratagene, La Jolla, CA, USA). A 4.5 kb BamHI-SmaI fragment located in intron 1 was thereafter inserted between the BglII and XhoI sites after inserting a SalI linker into the SmaI site. A PCR-generated 1 kb BamHIHindIII fragment that includes the 3' part of the putative exon 2 through the putative exon 4 was next inserted between the BamHI and HindIII sites of the vector. The Matriptase/ MT-SP1 targeting vector was further furnished with ā anking Herpes simplex virus-thymidine kinase expression cassette inserted into the RsrII site to provide a means of selection against random insertion of the targeting vector. The targeting vector was introduced into HM-1 ES cells (Magin et al., 1992) by electroporation and ES cell clones were selected in HAT medium (Gibco ± BRL, Gaithersburg, MD) and 2 mM ganciclovir (Syntex, Clarecastle, Ireland). Resistant ES cell clones were isolated, expanded, and screened for homologous recombination of the targeting vector into the Matriptase/MT-SP1 locus by PCR using a primer complementary to the promoter region of the PGK-HPRT minigene (p01, 5'-GTGCGAGGCCAGAGGC-CACTTGTGTAGCG-3') and a primer complementary to a sequence of the Matriptase/MT-SP1 gene located downstream of the short arm of the targeting vector (p02, 5'-CTCAGTGCCACAGAAAATAAATGA-3').
Matriptase/ MT-SP1 gene targeting was veri®ed by Southern blot hybridization of XhoI-digested genomic DNA using a 32 Plabeled 700 bp XhoI-BamHI probe that was external to the targeting vector sequences. Matriptase/MT-SP1-targeted ES cells were injected into the blastocoel cavity of C57B1/6J-derived blastocysts and implanted into pseudopregnant females. Chimeric male ospring was bred to NIH Black Swiss females (Taconic Farms, Germantown, NY, USA) to generate heterozygous ospring. These mice were subsequently interbred to generate homozygous Matriptase/MT-SP1 7/7 progeny. Genotyping of mice was performed by PCR ampli®cation of DNA from ear or tail biopsies with the primers p03 (5'-GCATGCTCCAGACTGCCTTG-3') and p04 (5'-GTGGAGGTGGAGTTCTCATACG-3') to detect the presence of the targeted Matriptase/MT-SP1 allele, and p05 (5'-CAGTGCTGTTCAGCTTCCTCTT-3') and p04 (5'-GTGGAGGTGGAGTTCTCATACG-3') to detect the wild type Matriptase/MT-SP1 allele).
RNA preparation and Northern blot analysis
Whole newborn pups were euthanized, snap-frozen in liquid nitrogen, and ground to a ®ne powder with a mortar and pestle. Total RNA was prepared by extraction in Trizol reagent (Gibco ± BRL), as recommended by the manufacturers. Samples (1 mg) were fractionated electrophoretically on formaldehyde agarose gels, blotted onto NytranSuper Charge nylon membranes (Schleicher and Schuell, Keene, NH, USA), hybridized to a 32 P-labeled 3.5 kb Matriptase/ MT-SP1 expressed sequence tag (EST) probe (I.M.A.G.E. ID 2609399) that contains the complete full-length murine Matriptase/MT-SP1 cDNA, and subjected to PhosphorImage analysis using ImageQuant software from Molecular Dynamics (Molecular Dynamics, Sunnyvale, CA, USA).
RT ± PCR
Total RNA from newborn pups was ampli®ed by reverse transcription followed by PCR ampli®cation using Ready-togo TM RT ± PCR beads (Amersham Pharmacia Biotech Inc, Piscataway, NJ, USA), as recommended by the manufacturers. First strand cDNA synthesis was performed using a Matriptase/MT-SP1-speci®c primer (p06, 5'-AGGCAGTTA-CAGCCGACTTCTT-3') complementary to the putative exon 4 sequences (nt. 477 ± 498 of the murine Matriptase/MT-SP1 cDNA sequence, (Kim et al., 1999) . The subsequent PCR ampli®cation (annealing temperature 558C, denaturation temperature 928C, extension temperature 728C, 40 cycles) was performed with the ®rst strand primer in combination with a putative exon 1-speci®c primer (p07, 5'-AAC-CATGGGTAGCAATCGGGGC-3') corresponding to nt. 59 ± 80 of Matriptase/MT-SP1 (Kim et al., 1999) . The RT ± PCR products were excised from agarose gels following electrophoresis, puri®ed, and cloned using the TopoTA cloning vector system (Invitrogen, Carlsbad, CA, USA) and subsequently analysed by DNA sequencing.
Histological analysis
Newborn to 48 h old pups were ®xed for 24 h in 4% paraformaldehyde (PFA) in PBS, processed into paran, sectioned into parallel sagittal section, and stained with h and e, or periodic acid-Schi. For toluidine blue staining, pups were ®xed by intracardial perfusion with 1% glutaraldehyde, ®xed for further 24 h in the same ®xative, and embedded in epon. One mm sections were stained with hot toluidine blue and examined by light microscopy. For transmission electron microscopy, the tissues were post®xed in 1% aqueous OsO4 and stained en bloc with 0.2% uranyl acetate. After dehydration, embedding in epon, sectioning, and staining with uranyl acetate and lead citrate, the tissues were examined with a Phillips CM12 transmission electron microscope.
Scanning electron microscopy
Tissues were ®xed in 4% formaldehyde/4% glutaraldehyde on 0.1 M cacodylate buer, pH 7.4, for 3 days, rinsed in cacodylate buer and incubated overnight in 2% glycine, overnight in 2% tannic acid pH 4.0, and 6 h in 2% OsO4. The ®xed tissues were dehydrated in graded ethanol solutions, put under vacuum for 2 h, mounted onto stubs with Leit-C adhesive (Electron Microscopy Sciences, Fort Washington, PA, USA) and were examined with a Hitachi S-3500N variable pressure scanning electron microscope.
Immunohistochemistry
For visualization of epidermal structural antigens, sections of newborn skin were mounted on cardboard and ®xed for 24 h in 90% ethanol, processed into paran, and sectioned. Antigens were retrieved by the boiling of sections for 20 min in DAKO retrieval buer (DAKO, Carpinteria, CA, USA), blocked with 2% bovine serum albumin, and incubated overnight at 48C with rabbit antibodies to mouse keratin 1, 5, 10, 14, ®llagrin, and loricrin (Covance, Richmond, CA, USA). Bound antibodies were visualized with a Vectastain ABC peroxidase kit (vector Laboratories, Burlingame, CA, USA) using diaminobenzidine as chromogenic substrate. Apoptosis staining was performed on parasagittal sections of whole newborn pups ®xed for 24 h in 4% PFA using TdT incorporation of digoxigenin-dUTP, and visualization of incorporated digoxigenin-dUTP by horseradish peroxidaselabeled anti-digoxigenin antibodies and new fuchin chromogen (DAKO). Cell proliferation was visualized by staining of PFA-®xed tissues with monoclonal proliferation cell nuclear antigen antibodies, and visualization of bound antibodies with a Vectastain ABC peroxidase kit and diaminobenzidine.
Skin permeability assay
Newborn mice were euthanized and subjected to methanol dehydration and subsequent rehydration as described (Koch et al., 2000) . The pups were then washed in PBS for 1 min and stained overnight at room temperature in 0.1% Toluidine Blue/PBS (Fisher Scienti®c, Pittsburgh, PA, USA), destained for 15 min in PBS at room temperature and examined with a dissection microscope for epidermal due penetration.
Transepidermal fluid loss assay
Newborn pups from Matriptase/MT-SP1 +/7 parents were separated from their mother to prevent¯uid intake and placed in a 378C incubator. The rate of epithelial¯uid loss was estimated by measuring the reduction of body weight of the individual pups as a function of time over a period of 5 h.
Flow cytometry analysis
Cell staining for surface markers was performed essentially as described (Chen et al., 2001) . Brie¯y, thymocytes from newborn pups were isolated, stained simultaneously with phycoerythrin-conjugated CD4 antibodies,¯uorescein-conjugated CD8 antibodies (both from BD/PharMingen, San Diego, CA, USA), and 7-amino-actinomycin D (Calbiochem-Novabiochem, San Diego, CA, USA). Cell subsets were gated and 7-amino-actinomycin D staining on¯uorescence channel-3 versus forward scatter channel was displayed.
